Lead Product(s) : Undisclosed
Therapeutic Area : Cardiology/Vascular Diseases
Study Phase : Discovery
Sponsor : Icahn School of Medicine
Deal Size : Undisclosed
Deal Type : Collaboration
Details : The collaboration aims to work on developing exosome-encapsulated AAV (exoAAV) vectors as a novel gene delivery technology aimed at improving treatments for heart disease.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Undisclosed
April 08, 2023
Lead Product(s) : Undisclosed
Therapeutic Area : Cardiology/Vascular Diseases
Highest Development Status : Discovery
Sponsor : Icahn School of Medicine
Deal Size : Undisclosed
Deal Type : Collaboration